Pulmonary Hypertension

May 2, 2016May 2, 2016

Pulmonary Hypertension Association Appoints New President and CEO

The Pulmonary Hypertension Association (PHA) has named a new president and chief executive officer, Brad A. Wong, of San Rafael, California. Wong will take on his new role June 19 at the ... Read more

April 26, 2016April 28, 2016

Pulmonary Hypertension Association Launches ‘PH Care for All’ to Study Treatment Disparities

News, Pulmonary Hypertension

The Pulmonary Hypertension Association (PHA) recently assembled 26 pulmonary hypertension (PH) specialists to launch “PH Care for All,” an initiative to examine and address treatment discrepancies for minorities and low-income ... Read more

April 18, 2016April 19, 2016

Karos Pharmaceuticals Advances PAH Drug Candidate into the Clinic

News, Pulmonary Hypertension

Karos Pharmaceuticals recently announced it has advanced its small molecule investigational drug candidate, KAR5585, into the clinic for the treatment of pulmonary arterial hypertension (PAH) and other rare conditions marked ... Read more

April 15, 2016April 18, 2016

New Lung Transplant Program Opens at Memorial Hermann in Houston

COPD, Cystic Fibrosis, News, Pulmonary Hypertension

Memorial Hermann-Texas Medical Center (TMC) recently announced its new Lung Transplant Program, which offers lung and all solid organ transplants, including the kidney, liver, and heart. The Centers for Disease Control and Prevention ... Read more

April 14, 2016April 19, 2016

Study Reports Unrecognized Pulmonary Hypertension in Pulmonary Embolism Patients

News, Pulmonary embolism, Pulmonary Hypertension

A retrospective study sponsored by Bayer suggested that many patients who suffered from pulmonary embolism have a higher risk of developing chronic thromboembolic pulmonary hypertension (CTEPH), a life-threatening form of pulmonary ... Read more

April 8, 2016April 8, 2016

Uptravi for Treatment of PAH Gets Postive Opinion from EMA Committee; EC Decision Expected Soon

News, Pulmonary Hypertension

Actelion recently announced in a press release that the European Medicines Agency (EMA)’s Committee for Medicinal Products for Human Use (CHMP) has reconsidered and re-adopted its positive opinion for the ... Read more

April 7, 2016April 7, 2016

Researcher at ACC Meeting Presents PH Diagnosis, Monitoring Device PulmoBind

News, Pulmonary Hypertension

At the American College of Cardiology (ACC) meeting in Chicago this month, a researcher from the Montreal Heart Institute (MHI) in Canada presented the results of a Phase 2 clinical trial showing the safety of ... Read more

April 5, 2016April 5, 2016

Pulmonary Hypertension Association Accredits 2 New PH Care Centers

News, Pulmonary Hypertension

The Pulmonary Hypertension Association recently accredited two new Centers of Comprehensive Care (CCC) as part of the Pulmonary Hypertension Care Centers (PHCC) initiative. Care centers are now open in 23 states, providing ... Read more

April 4, 2016April 4, 2016

In PAH Patients, Study Finds Combo Therapy Reduces Risk of Clinical Worsening

News, Pulmonary Hypertension

A new study found that the use of combination therapy in patients with pulmonary arterial hypertension (PAH) considerably reduced their risk of clinical worsening, compared to using a single therapy. The study, ... Read more

April 1, 2016April 4, 2016

EMA Grants Orphan Medicinal Status to Eiger’s PAH Treatment Ubenimex

News, Pulmonary Hypertension

The European Medicines Agency (EMA) has granted Orphan Medicinal Product status to Eiger BioPharmaceuticals‘ Bestatin (ubenimex) for the treatment of pulmonary arterial hypertension (PAH). “We are very pleased with the EMA ... Read more